# Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir

> **NCT02442700** · PHASE4 · COMPLETED · sponsor: **Ramathibodi Hospital** · enrollment: 24 (actual)

## Conditions studied

- HIV
- Dyslipidemia

## Interventions

- **DRUG:** pitavastatin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02442700
- **Lead sponsor:** Ramathibodi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02442700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02442700, "Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT02442700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*